A Vanderbilt study finds that standard genetic tests for lamotrigine reaction risk omit HLA-A*32:01, a marker linked to severe DRESS, raising concerns about current pharmacogenomic panel effectiveness.
As early peanut introduction becomes more common, component testing is playing a larger role in distinguishing allergy from sensitization.
rex Laboratories has launched BiomeBurden, a comprehensive test that evaluates immune responses to microbial, yeast, and mold triggers.
Werfen’s Aptiva APS IgG and IgM Reagents for antiphospholipid syndrome (APS) diagnosis address a need in autoimmune disease diagnostics.
Read More
Researchers developed an AI-powered Genetic Progression Score to predict autoimmune disease progression from preclinical stages.
Read More
Exagen added new biomarkers to its AVISE CTD platform, enhancing diagnostic accuracy for SLE and rheumatoid arthritis (RA).
Read More
Augurex Life Sciences and Quest partnered to introduce the 14-3-3η biomarker-based test for rheumatoid arthritis across the U.S.
Read More
Researchers identified genes closely linked to both rheumatoid arthritis and osteoporosis, offering diagnostic markers for these diseases.
Read More
Augurex Life Sciences and ARUP Labs collaborated on a test to detect rheumatoid arthritis for improved early diagnostic capabilities.
Read More
A mast cell activation test mimics allergic reactions in a test tube, offering a more precise alternative to food allergy diagnostics.
Read More
ALK introduced new FDA-approved AccuTest line of allergy skin testing devices and allergen well trays for allergy testing and diagnosis.
Read More
DiaCarta secured a contract with the San Francisco VA Health Care System to provide VEXAS syndrome testing for veterans.
Read More
Thermo Fisher’s Phadia Laboratory Systems enhance the precision and speed of diagnosing autoimmune diseases, such as rheumatoid arthritis.
Read More
ACCU Reference Medical Lab launched molecular PCR panels for better diagnosis of tick-borne diseases to provide for better patient outcomes.
Read More
AliveDx received IVDR CE mark for its microarray immunoassay to detect a specific IgE directed to a protein allergen in human serum.
Read More
A new study reveals that 80% of asthma patients suffer from allergic rhinitis, with significant skin test reactivity to various allergens.
Read More
New research links specific genetic mutations to subsets of lupus patients, enabling personalized treatments that target toll-like receptors.
Read More
AMPEL BioSolutions’ predictive AI-driven blood test for Lupus forecasts patient flares and drug targets from gene expression.
Read More